These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6528943)

  • 1. Invasive malignant melanomas lacking competence for metastasis.
    Elder DE; Guerry D; Epstein MN; Zehngebot L; Lusk E; Van Horn M; Clark WH
    Am J Dermatopathol; 1984; 6 Suppl():55-61. PubMed ID: 6528943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging.
    Gimotty PA; Guerry D; Ming ME; Elenitsas R; Xu X; Czerniecki B; Spitz F; Schuchter L; Elder D
    J Clin Oncol; 2004 Sep; 22(18):3668-76. PubMed ID: 15302909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
    Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features.
    Elder DE; Gimotty PA; Guerry D
    Dermatol Ther; 2005; 18(5):369-85. PubMed ID: 16297012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma progression.
    Gorski DH; Leal AD; Goydos JS
    J Am Coll Surg; 2003 Sep; 197(3):408-18. PubMed ID: 12946796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiotherapy of malignant melanoma of the skin].
    Suter L; Fuhrmann D
    Praxis (Bern 1994); 2001 Mar; 90(10):397-402. PubMed ID: 11305185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous melanomas that defy conventional prognostic indicators.
    McCarthy WH; Shaw HM; McCarthy SW; Rivers JK; Thompson JF
    Semin Oncol; 1996 Dec; 23(6):709-13. PubMed ID: 8970591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thin melanomas.
    King R; Googe PB; Mihm MC
    Clin Lab Med; 2000 Dec; 20(4):713-29. PubMed ID: 11221511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histopathology of cutaneous malignant melanoma.
    Barnhill RL; Mihm MC
    Semin Diagn Pathol; 1993 Feb; 10(1):47-75. PubMed ID: 8506417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group.
    Cook MG; Spatz A; Bröcker EB; Ruiter DJ
    J Pathol; 2002 Jun; 197(2):188-93. PubMed ID: 12015742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
    J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proliferative activity of cells of malignant melanomas.
    Pierard GE; Pierard-Franchimont C
    Am J Dermatopathol; 1984; 6 Suppl():317-23. PubMed ID: 6528936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002.
    Aquilina S; Dalmas M; Calleja N; Gatt P; Scerri L
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):958-63. PubMed ID: 16922945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.
    Einwachter-Thompson J; MacKie RM
    Br J Dermatol; 2008 Aug; 159(2):337-41. PubMed ID: 18510665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic model of progression of cutaneous melanoma population.
    Gutkowicz-Krusin D; Rabinovitz HS
    Melanoma Res; 2007 Dec; 17(6):354-9. PubMed ID: 17992117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
    Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
    Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein D expression in cutaneous malignant melanoma.
    Miranda E; Vizoso F; Martín A; Quintela I; Corte MD; Seguí ME; Ordiz I; Merino AM
    J Surg Oncol; 2003 Jun; 83(2):99-105. PubMed ID: 12772203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An epidemiological study of the distinct histological types of cutaneous melanoma in relation to other variables of the disease].
    Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Agudo Ferrándiz J; Segarra Castelló L
    Rev Clin Esp; 1992 Mar; 190(4):169-76. PubMed ID: 1589611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.